Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
S01KX01 S01KX01 chymotrypsin
S01L S01L Ocular vascular disorder agents
S01LA S01LA Antineovascularisation agents
S01LA01 S01LA01 verteporfin
S01LA02 S01LA02 anecortave
S01LA03 S01LA03 pegaptanib
S01LA04 S01LA04 ranibizumab
S01LA05 S01LA05 Aflibercept
S01LA06 S01LA06 Brolucizumab
S01LA09 S01LA09 Faricimab
S01X S01X Other ophthalmologicals
S01XA S01XA Other ophthalmologicals
S01XA01 S01XA01 guaiazulen
S01XA02 S01XA02 retinol
S01XA03 S01XA03 sodium chloride, hypertonic
S01XA04 S01XA04 potassium iodide
S01XA05 S01XA05 sodium edetate
S01XA06 S01XA06 ethylmorphine
S01XA07 S01XA07 alum
S01XA08 S01XA08 acetylcysteine
S01XA09 S01XA09 iodoheparinate
S01XA10 S01XA10 inosine
S01XA11 S01XA11 nandrolone
S01XA12 S01XA12 dexpanthenol
S01XA13 S01XA13 alteplase
S01XA14 S01XA14 heparin
S01XA15 S01XA15 ascorbic acid
S01XA18 S01XA18 Ciclosporin
S01XA19 S01XA19 limbal stems cells, autologous
S01XA20 S01XA20 artificial tears and other indifferent preparations
Showing 30 of 6884 Records